Experienced in Jervell Lange-Nielsen Syndrome (JLNS)

Peter Monksfield

Birmingham, ENG, GB 
Experienced in Jervell Lange-Nielsen Syndrome (JLNS)
Birmingham, ENG, GB 
OverviewLocationsClinical Research

Overview

Peter Monksfield practices in Birmingham, United Kingdom. Mr. Monksfield is rated as an Experienced expert by MediFind in the treatment of Jervell Lange-Nielsen Syndrome (JLNS). His top areas of expertise are Hearing Loss, Familial Otosclerosis, Otosclerosis, and CAPOS Syndrome.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Jervell Lange-Nielsen Syndrome (JLNS).

Gender
Male

Locations

Birmingham, ENG, United Kingdom
Other Locations
Mindelsohn Way Edgbaston Birmingham UK, Edgbaston, ENG, United Kingdom
Radcliffe Infirmary
Oxford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Multi-center, Single-arm, Clinical Investigation of the Safety and Performance of the Sentio System in Users With Mixed/Conductive Hearing Losses and Single Sided Deafness
A Prospective, Multi-center, Single-arm, Clinical Investigation of the Safety and Performance of the Sentio System in Users With Mixed/Conductive Hearing Losses and Single Sided Deafness
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Unilateral Subjective Tinnitus
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Unilateral Subjective Tinnitus
Enrollment Status: Completed
Publish Date: January 06, 2023
Intervention Type: Drug
Study Drug: OTO-313
Study Phase: Phase 2
View 1 Less Clinical Trial

51 Total Publications

Long-Term Patient Satisfaction and Surgical Outcomes With Sophono Implants: A Single-Institution Experience.
Long-Term Patient Satisfaction and Surgical Outcomes With Sophono Implants: A Single-Institution Experience.
Journal: Cureus
Published: October 21, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Monksfield's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile